Expand TSHA Menu
TSHA MENU

TSHA Latest Press Releases

-- December 5, 2025 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 4, 2025 --

Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- October 28, 2025 --

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4 Globe Newswire 8:00 AM

-- October 16, 2025 --

Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome Globe Newswire 4:01 PM

-- October 9, 2025 --

Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting Globe Newswire 8:00 AM

-- October 3, 2025 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- October 2, 2025 --

Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome Globe Newswire 8:00 AM

-- September 5, 2025 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- August 12, 2025 --

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 8:01 AM

-- August 5, 2025 --

Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12 Globe Newswire 4:05 PM

-- August 1, 2025 --

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:06 PM
Market Data Delayed 15 Minutes